AKTX vs CRNX
Akari Therapeutics, Plc · Crinetics Pharmaceuticals, Inc.
Relative return (rebased to 100)
Key stats
| Metric | AKTX | CRNX |
|---|---|---|
| Price | $7.00 | $84.08 |
| Market Cap | $640.97B | $8.87B |
| P/E | — | — |
| P/B | 44573.65 | 6.92 |
| P/S | 1742346.13 | 1151.95 |
| ROE | -120.3% | -36.3% |
| Net Margin | -4702.1% | -6046.2% |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | 640.7% |
| Dividend Yield | — | — |
| EPS | -$0.00 | -$4.41 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.